Bristol-Myers Squibb (BMY)
NYSE: BMY
· Real-Time Price · USD
48.55
-1.20 (-2.41%)
At close: Jun 16, 2025, 3:59 PM
48.62
0.14%
After-hours: Jun 16, 2025, 07:59 PM EDT
Revlimid Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.77B | 5.34B | +1230.18% |
| Dec 31, 2023 | 434M | 184M | +73.60% |
| Dec 31, 2022 | 250M | n/a | n/a |
| Dec 31, 2021 | n/a | n/a | n/a |
| Dec 31, 2020 | n/a | n/a | n/a |
| Dec 31, 2019 | n/a | n/a | n/a |
| Dec 31, 2018 | n/a | n/a | n/a |
| Dec 31, 2017 | n/a | n/a | n/a |
| Dec 31, 2016 | n/a | n/a | n/a |
| Dec 31, 2015 | n/a | n/a | n/a |
| Dec 31, 2014 | n/a | n/a | n/a |
| Dec 31, 2013 | n/a | n/a | n/a |
| Dec 31, 2012 | n/a | n/a | n/a |